GlassScriptPhysician profile
Melanie Neuner
NPI 1083498646
$2,084.44
in general payments reported to CMS, 2019-2025
16 companies · $998 in 2025
The $998 reported for 2025 was more than what 87% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $114 · 2024: $972 · 2025: $998.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,084.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,084.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $617.13 | 2024-2025 | Airsupra, Farxiga, Lokelma |
| Novo Nordisk INC | $269.49 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Neurocrine Biosciences, INC. | $254.05 | 2023-2025 | Ingrezza |
| Abbvie INC. | $234.81 | 2024-2025 | |
| Edwards Lifesciences Corporation | $122.95 | 2025 | |
| Insulet Corporation | $114.46 | 2025 | Omnipod |
| Boston Scientific Corporation | $108.12 | 2024 | Watchman Flx |
| Phathom Pharmaceuticals, INC. | $101.50 | 2025 | Voquezna |
| Merck Sharp & Dohme LLC | $75.52 | 2024-2025 | Capvaxive, Gardasil, Gardasil 9 |
| Philips North America LLC | $35.33 | 2024 | (Ck7) Extended Holter |
| Lilly USA, LLC | $32.95 | 2024-2025 | Zepbound, Mounjaro |
| Otsuka America Pharmaceutical, INC. | $30.65 | 2025 | Rexulti |
| Dexcom, INC. | $28.84 | 2024 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.89 | 2025 | Xifaxan |
| Pfizer INC. | $18.33 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $15.42 | 2024 | Otezla, Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Neuner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.